NEBION innovation  

CTI Innovation Projects

The Swiss Commission for Technology and Innovation (CTI) co-funded a project in partnership with ETH. The project led to the development of novel methods for large-scale biological data integration, data curation, and to the development of ontologies. A further CTI project in partnership with several academic institutions and start-up companies is running in the field of biomarker discovery in cancer and cardiovascular diseases.

SystemsX Bridge-to-Industry Project

Nebion and ETH Zurich have partnered to develop novel methodologies for the integration and visualization of biclustering results. The project is co-funded by and Nebion. See also project page at Systems X.

European FP7 Projects

Nebion is a member of two large European research projects, one in cardiovascular disease research and the other in plant biology.

  • TransCard is an EU FP7 collaborative project to identify, prioritize and validate existing and emerging targets and novel key regulators of lipid and lipoprotein metabolism. The acronym stands for "Translating disease to cardiovascular health". As partner of this project, Nebion will use its technologies to identify novel targets and prioritize the consortium's markers, identify novel genes associated with these diseases, curate and integrate CVD-related datasets and develop specific tools. See also project website.

  • 3to4 is a large EU FP7 collaborative project to uncover mechanisms underlying important aspects of the C4 leaf and study ways to transfer C4 traits to C3 plants. As an SME, Nebion will provide expertise and services to manage the consortium's high-throughput biological data, develop novel tools and support data analysis. See also project website

Nebion Partnership Projects

Nebion conducts several additional innovative projects with various partners in the field of target identification, biomarker search, gene expression and next generation sequencing.

CTI logo

SystemsX logo

FP7 logo

FP7 logo

FP7 logo